Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J. Carlo Cannell, Cannell Capital Add to Position in Hooper Holmes

J. Carlo Cannell is bullish on Hooper Holmes, Inc. (NYSEMKT:HH), and according to a recent Form 4 filing with the Securities and Exchange Commission, Cannell’s fund Cannell Capital has revealed the acquisition of 96,225 shares, in three transactions, at prices between $0.45 and $0.46 per share. Following the deals, Cannell Capital’s position has been increased to 10,042,991 shares. With Hooper Holmes currently trading at $0.52 apiece, Cannell’s investment is worth $5.2 million.

hooper holmes

Chuck Royce, the manager of Royce & Associates, has liquidated the fund’s stake in Hooper Holmes. Having previously owned 1.8 million shares, Royce & Associates has reported in the latest 13F filing no ownership of Hooper Holmes stock. Jim Simons‘ Renaissance Technologies has also reduced its stake. According to the latest 13F report, the fund has decreased the holding of Hooper Holmes stock by 45,000 shares to 869,000 shares reportedly worth $409,000.

Hooper Holmes provides life and health insurance companies with services of health risk assessment. At the end of September, the company reported the sale of Portamedic service line. American Para Professional Systems, Inc. paid $81 million in cash for the division and allowed Hooper Holmes to retain its existing Portamedic working capital. Ronald Aprahamian, Chairman of the Board, said:

As a result of this transaction, we have improved our balance sheet with cash on hand, and can now provide improved services to our current clients and pursue the growing Health and Wellness industry. We believe these efforts will lead us to profitable operations and provide improved results for our shareholders.

On September 26th, the company announced the promotion of Tom Collins to the position of Chief Financial Officer. Collins previously held the position of Senior Vice President of Operations for Hooper Holmes’ Portamedic division.

The company’s shares have a beta of 1.91, making it a rather volatile stock, and it currently pays no dividend. For the third quarter of 2013, Hooper Holmes reported revenues of $10.9 million and a loss per diluted share of $0.05.

Disclosure: none

Recommended reading:

Edward Lampert, ESL Investments Reduce Stake in AutoNation

GL Partners Adds to Position in SciClone Pharmaceuticals; Reveals New Stake in China Biologic Products

Hedge Fund News: Kyle Bass, Edward Lampert & David Tepper

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!